Binnendijk, K.H. and Rijkers, G.T., 2013. What is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probiotics. Beneficial Microbes 4: 223-230.

'What is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probiotics ' () 4 Beneficial Microbes : 223 -230.

What is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probioticsBeneficial Microbes4223230)| false
• Search Google Scholar

El Aidy, S., Derrien, M., Aardema, R., Hooiveld, G., Richards, S.E., Dane, A., Dekker, J., Vreeken, R., Levenez, F., Dore, J., Zoetendal, E.G., Van Baarlen, P. and Kleerebezem, M., 2014. Transient inflammatory-like state and microbial dysbiosis are pivotal in establishment of mucosal homeostasis during colonisation of germ-free mice. Beneficial Microbes 5: 67-77.

'Transient inflammatory-like state and microbial dysbiosis are pivotal in establishment of mucosal homeostasis during colonisation of germ-free mice ' () 5 Beneficial Microbes : 67 -77.

Transient inflammatory-like state and microbial dysbiosis are pivotal in establishment of mucosal homeostasis during colonisation of germ-free miceBeneficial Microbes56777)| false
• Search Google Scholar

Geurts, L., Neyrinck, A.M., Delzenne, N.M., Knauf, C. and Cani, P.D., 2014. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Beneficial Microbes 5: 3-17.

'Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics ' () 5 Beneficial Microbes : 3 -17.

Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebioticsBeneficial Microbes5317)| false
• Search Google Scholar

Greenway, F., Wang, S. and Heiman, M., 2014. A novel cobiotic containing a prebiotic and an antioxidant augments the glucose control and gastrointestinal tolerability of metformin: a case report. Beneficial Microbes 5: 29-32.

'A novel cobiotic containing a prebiotic and an antioxidant augments the glucose control and gastrointestinal tolerability of metformin: a case report ' () 5 Beneficial Microbes : 29 -32.

A novel cobiotic containing a prebiotic and an antioxidant augments the glucose control and gastrointestinal tolerability of metformin: a case reportBeneficial Microbes52932)| false
• Search Google Scholar

Hayes, C.L., Natividad, J.M.M., Jury, J., Martin, R., Langella, P. and Verdu, E.F., 2014. Efficacy of Bifidobacterium breve NCC2950 against DSS-induced colitis is dependent on bacterial preparation and timing of administration. Beneficial Microbes 5: 79-88.

'Efficacy of Bifidobacterium breve NCC2950 against DSS-induced colitis is dependent on bacterial preparation and timing of administration ' () 5 Beneficial Microbes : 79 -88.

Efficacy of Bifidobacterium breve NCC2950 against DSS-induced colitis is dependent on bacterial preparation and timing of administrationBeneficial Microbes57988)| false
• Search Google Scholar

Mekkes, M.C., Weenen, T.C., Brummer, R.J. and Claassen, E., 2014. The development of probiotic treatment in obesity: a review. Beneficial Microbes 5: 19-28.

'The development of probiotic treatment in obesity: a review ' () 5 Beneficial Microbes : 19 -28.

The development of probiotic treatment in obesity: a reviewBeneficial Microbes51928)| false
• Search Google Scholar

Remely, M., Aumueller, E., Jahn, D., Hippe, B., Brath, H. and Haslberger, A., 2014. Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity. Beneficial Microbes 5: 33-43.

'Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity ' () 5 Beneficial Microbes : 33 -43.

Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesityBeneficial Microbes53343)| false
• Search Google Scholar

Smug, L.N., Salminen, S., Sanders, M.E. and Ebner, S., 2014. Yoghurt and probiotic bacteria in dietary guidelines of the member states of the European Union. Beneficial Microbes 5: 61-66.

'Yoghurt and probiotic bacteria in dietary guidelines of the member states of the European Union ' () 5 Beneficial Microbes : 61 -66.

Yoghurt and probiotic bacteria in dietary guidelines of the member states of the European UnionBeneficial Microbes56166)| false
• Search Google Scholar

Van den Nieuwboer, M., Claassen, E., Morelli, L., Guarner, F., and Brummer, R.J., 2014. Probiotic and Synbiotic safety in infants under two years of age. Beneficial Microbes 5: 45-60.

'Probiotic and Synbiotic safety in infants under two years of age ' () 5 Beneficial Microbes : 45 -60.

Probiotic and Synbiotic safety in infants under two years of ageBeneficial Microbes54560)| false
• Search Google Scholar